Therapy News and Research

RSS

Researchers to test early intervention for caregivers of patients with serious illnesses or injuries

An early intervention developed for caregivers of patients with serious illnesses or injuries will be tested by researchers at The University of Texas Health Science Center at Houston.

25 Jun 2021

Muscles lose their smallest, most basic building blocks after stroke

After suffering a stroke, patients often are unable to use the arm on their affected side. Sometimes, they end up holding it close to their body, with the elbow flexed.

25 Jun 2021

UTHSC researchers publish new findings on how obesity impacts cancer treatments

Liza Makowski, PhD, professor in the Department of Medicine and the UTHSC Center for Cancer Research, has long been interested in how the immune system is altered by obesity and how this impacts cancer risk and treatment.

25 Jun 2021

New statement addresses current controversies and evolving concepts in thyroid cancer care

The American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and Molecular Imaging released a joint statement on three key topics addressing controversies in thyroid cancer care.

25 Jun 2021

Mayo Clinic researchers are working toward new CAR-T cell treatment for multiple myeloma

Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma.

25 Jun 2021

Over-the-counter antacids may improve glucose levels in people with diabetes

Antacids improved blood sugar control in people with diabetes but had no effect on reducing the risk of diabetes in the general population, according to a new meta-analysis published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

25 Jun 2021

Olympus Wins a 2021 Edison Award for Automated Cell Culture System

Olympus is proud to announce its OLYMPUS Provi™ CM20 incubation monitoring system won a Bronze Edison Award in the Cellular Research and Disease Prevention category for its innovative design that automates the cell culture workflow.

From Evident Corporation - Life Sciences 25 Jun 2021

Anti-inflammatory nanoparticles could be applied to the weakening muscles of DMD patients

Muscular dystrophies are a group of genetic diseases that lead to the progressive loss of muscle mass and function in patients, with the incurable Duchenne Muscular Dystrophy (DMD), which affects all the body's muscles primarily in boys, being particularly severe.

25 Jun 2021

FTO enzyme plays a key role in the deadly process of cancer metastasis

When cancers metastasize, cells from the primary tumor break away, travel through the blood or lymph system, and form new tumors in other body parts. Although metastasis are responsible for more than 90% of all cancer deaths, limited progress has been made in treating cancers that have spread.

25 Jun 2021

Remdesivir caused dangerously low heart rate in COVID-19 patients

After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment.

25 Jun 2021

New resource could make targeted cancer therapies more accessible for Australian patients

A new resource developed at the Garvan Institute of Medical Research and The Kinghorn Cancer Centre for oncologists could help make targeted cancer therapies more accessible for Australian patients.

25 Jun 2021

Study investigates difficulty swallowing in critically ill COVID-19 patients

Researchers from Clinica Luganese Moncucco and Bellinzona Regional Hospital in Switzerland investigated the prevalence of swelling disorders in severely ill COVID-19 patients and reported their results in a paper posted to the medRxiv* preprint server.

25 Jun 2021

New findings shed light on genetic changes that underlie rare, aggressive childhood cancer

A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma after revealing key genetic changes underlying development of the disease.

24 Jun 2021

New study revises current textbook knowledge about gastrulation

Scientists from Helmholtz Zentrum München revise the current textbook knowledge about gastrulation, the formation of the basic body plan during embryonic development. Their study in mice has implications for cell replacement strategies and cancer research.

24 Jun 2021

City of Hope researchers identify how breast cancer cells acquire resistant traits

City of Hope, a world-renowned cancer research and treatment center, has identified how cancer cells in patients with early-stage breast cancer change and become resistant to hormone or combination therapies, according to a new study published in Nature Cancer.

24 Jun 2021

New dietary fiber formulation improves the potency of cancer immunotherapies

Many people don't realize that the trillions of bacteria, viruses, and fungi residing within the gastrointestinal tract--collectively called the gut microbiome-- are connected to overall health, and specifically to cancer.

24 Jun 2021

FDA issues draft guidance encouraging rational expanded patient eligibility for oncology clinical trials

Today, the FDA issued a draft guidance encouraging industry to include patients with incurable cancers (when there is no potential for cure or for prolonged/near normal survival) in cancer clinical trials, regardless of whether they have received existing alternative treatment options.

24 Jun 2021

Long covid has reignited polarisation in approaches to treat chronic fatigue syndrome

Many long covid patients are experiencing extreme fatigue, a situation which has reignited the polarization in approaches to treatment and rehabilitation of chronic fatigue syndrome, according to a special report today.

24 Jun 2021

Researchers uncover new function of regulator protein in multiple myeloma development

A specific regulatory protein significantly influences the development of tumor-inducing blood vessels in the bone marrow of blood cancer patients.

24 Jun 2021

Researchers reanalyze COVID RECOVERY trial data on tocilizumab

A Bayesian analysis of the RECOVERY trial suggests the immunosuppressive drug tocilizumab can reduce deaths in hospitalized COVID-19 patients taking corticosteroids as well as patients on oxygen or non-invasive ventilation and likely increases hospital discharge rates. However, it is not clear if patients on invasive ventilation also benefit.

24 Jun 2021

Therapy News and Research

Researchers to test early intervention for caregivers of patients with serious illnesses or injuries

Muscles lose their smallest, most basic building blocks after stroke

UTHSC researchers publish new findings on how obesity impacts cancer treatments

New statement addresses current controversies and evolving concepts in thyroid cancer care

Mayo Clinic researchers are working toward new CAR-T cell treatment for multiple myeloma

Over-the-counter antacids may improve glucose levels in people with diabetes

Olympus Wins a 2021 Edison Award for Automated Cell Culture System

Anti-inflammatory nanoparticles could be applied to the weakening muscles of DMD patients

FTO enzyme plays a key role in the deadly process of cancer metastasis

Remdesivir caused dangerously low heart rate in COVID-19 patients

New resource could make targeted cancer therapies more accessible for Australian patients

Study investigates difficulty swallowing in critically ill COVID-19 patients

New findings shed light on genetic changes that underlie rare, aggressive childhood cancer

New study revises current textbook knowledge about gastrulation

City of Hope researchers identify how breast cancer cells acquire resistant traits

New dietary fiber formulation improves the potency of cancer immunotherapies

FDA issues draft guidance encouraging rational expanded patient eligibility for oncology clinical trials

Long covid has reignited polarisation in approaches to treat chronic fatigue syndrome

Researchers uncover new function of regulator protein in multiple myeloma development

Researchers reanalyze COVID RECOVERY trial data on tocilizumab

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News